open access
Hypersensitivity myocarditis and COVID-19 vaccines
Affiliations- Department of Cardiology, University of Patras Medical School, Patras, Greece
- Intensive Care Unit, University of Patras Medical School, Patras, Greece
- Department of Cardiology, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom
- Department of Internal Medicine, University of Patras, Patras, Greece
open access
Abstract
Abstract
About this articleTitle
Hypersensitivity myocarditis and COVID-19 vaccines
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Letter to the Editor
Pages
109-110
Published online
2021-12-01
Page views
4818
Article views/downloads
1479
DOI
10.33963/KP.a2021.0166
Pubmed
Bibliographic record
Kardiol Pol 2022;80(1):109-110.
Authors
Nicholas G Kounis
Virginia Mplani
Ioanna Koniari
Dimitrios Velissaris
References (5)- Sokolska JM, Kurcz J, Kosmala W. Every rose has its thorns — acute myocarditis following COVID-19 vaccination. Kardiol Pol. 2021; 79(10): 1153–1154.
- Witberg G, Barda N, Hoss S, et al. Myocarditis after COVID-19 vaccination in a large health care organization. N Engl J Med. 2021 [Epub ahead of print].
- Almpanis GC, Mazarakis A, Dimopoulos DA, et al. The conundrum of hypersensitivity cardiac disease: hypersensitivity myocarditis, acute hypersensitivity coronary syndrome (Kounis syndrome) or both? Int J Cardiol. 2011; 148(2): 237–240.
- Warren CM, Snow TT, Lee AS, et al. Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system. JAMA Netw Open. 2021; 4(9): e2125524.
- Maggio ET. Alkylsaccharides: circumventing oxidative damage to biotherapeutics caused by polyoxyethylene-based surfactants. Ther Deliv. 2013; 4(5): 567–572.
